The role of reactive oxygen species and metabolism on cancer cells and their microenvironment

Seminars in Cancer Biology

Volumn 25, Issue , 2014, Pages 23-32

  Costa, Ana ^a,b   Scholer Dahirel, Alix ^a,b   Mechta Grigoriou, Fatima ^a,b  

^a INSTITUT CURIE   (France)

^b INSTITUT CURIE   (France)

Author keywords

Actin; CAF heterogeneity; Caveolin; Mitochondria; Myofibroblast; Oxidative stress; PDGFR; ROS; Stroma

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHEMOKINE RECEPTOR CXCR4; COPPER ZINC SUPEROXIDE DISMUTASE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; OXIDOREDUCTASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROSTAGLANDIN SYNTHASE; PYRUVATE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SCATTER FACTOR RECEPTOR; STROMELYSIN; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CALCIUM SIGNALING; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CARCINOMA ASSOCIATED FIBROBLAST; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL INTERACTION; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; ENZYME REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; HUMAN; INFLAMMATION; METASTASIS INHIBITION; METASTASIS RESECTION; MOLECULAR INTERACTION; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; WOUND HEALING; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR INVASION;

ANIMALS; CELL DIFFERENTIATION; FIBROBLASTS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84897504519     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.12.007     Document Type: Review

References (143)

1. Gueraud F., Atalay M., Bresgen N., Cipak A., Eckl P.M., Huc L., et al. Chemistry and biochemistry of lipid peroxidation products. Free Radical Res 2010, 44:1098-1124.
2. Oakley F.D., Abbott D., Li Q., Engelhardt J.F. Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal 2009, 11:1313-1333.
3. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006, 97:1634-1658.
4. Dikalov S., Griendling K.K., Harrison D.G. Measurement of reactive oxygen species in cardiovascular studies. Hypertension 2007, 49:717-727.
5. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., et al. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 2004, 118:781-794.
6. Laurent G., Solari F., Mateescu B., Karaca M., Castel J., Bourachot B., et al. Oxidative stress contributes to aging by enhancing pancreatic angiogenesis and insulin signaling. Cell Metab 2008, 7:113-124.
7. Dolado I., Swat A., Ajenjo N., De Vita G., Cuadrado A. Nebreda AR. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 2007, 11:191-205.
8. Gommeaux J., Cano C., Garcia S., Gironella M., Pietri S., Culcasi M., et al. Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1. Mol Cell Biol 2007, 27:2215-2228.
9. Dudley S.C., Hoch N.E., McCann L.A., Honeycutt C., Diamandopoulos L., Fukai T., et al. Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 2005, 112:1266-1273.
10. Brand M.D. The sites and topology of mitochondrial superoxide production. Exp Gerontol 2010, 45:466-472.
11. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem J 2009, 417:1-13.
12. Sena L.A., Chandel N.S. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012, 48:158-167.
13. Bedard K., Krause K.H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007, 87:245-313.
14. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005, 10:1881-1896.
15. Lu W., Hu Y., Chen G., Chen Z., Zhang H., Wang F., et al. Novel role of NOX in supporting aerobic glycolysis in cancer cells with mitochondrial dysfunction and as a potential target for cancer therapy. PLoS Biol 2012, 10:e1001326.
16. Puntel R.L., Roos D.H., Grotto D., Garcia S.C., Nogueira C.W., Rocha J.B. Antioxidant properties of Krebs cycle intermediates against malonate pro-oxidant activity in vitro: a comparative study using the colorimetric method and HPLC analysis to determine malondialdehyde in rat brain homogenates. Life Sci 2007, 81:51-62.
17. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998, 95:11715-11720.
18. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003, 3:721-732.
19. Pouyssegur J., Mechta-Grigoriou F. Redox regulation of the hypoxia-inducible factor. Biol Chem 2006, 387:1337-1346.
20. Adachi Y., Shibai Y., Mitsushita J., Shang W.H., Hirose K., Kamata T. Oncogenic Ras upregulates NADPH oxidase 1 gene expression through MEK-ERK-dependent phosphorylation of GATA-6. Oncogene 2008, 27:4921-4932.
21. Kodama R., Kato M., Furuta S., Ueno S., Zhang Y., Matsuno K., et al. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence. Genes Cells 2013, 18:32-41.
22. Mitsushita J., Lambeth J.D., Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res 2004, 64:3580-3585.
23. Seru R., Mondola P., Damiano S., Svegliati S., Agnese S., Avvedimento E.V., et al. HaRas activates the NADPH oxidase complex in human neuroblastoma cells via extracellular signal-regulated kinase 1/2 pathway. J Neurochem 2004, 91:613-622.
24. Shinohara M., Shang W.H., Kubodera M., Harada S., Mitsushita J., Kato M., et al. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 2007, 282:17640-17648.
25. Toullec A., Gerald D., Despouy G., Bourachot B., Cardon M., Lefort S., et al. Oxidative stress promotes myofibroblast differentiation and tumour spreading. EMBO Mol Med 2010, 2:211-230.
26. Lim S.D., Sun C., Lambeth J.D., Marshall F., Amin M., Chung L., et al. Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 2005, 62:200-207.
27. Szanto I., Rubbia-Brandt L., Kiss P., Steger K., Banfi B., Kovari E., et al. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 2005, 207:164-176.
28. DeNicola G.M., Karreth F.A., Humpton T.J., Gopinathan A., Wei C., Frese K., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 2011, 475:106-109.
29. Mateescu B., Batista L., Cardon M., Gruosso T., de Feraudy Y., Mariani O., et al. miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011, 17:1627-1635.
30. Sporn M.B., Liby K.T. NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 2012, 12:564-571.
31. Batista L., Gruosso T., Mechta-Grigoriou F. Ovarian cancer emerging subtypes: role of oxidative stress and fibrosis in tumour development and response to treatment. Int J Biochem Cell Biol 2013, 45:1092-1098.
32. Hu Y., Rosen D.G., Zhou Y., Feng L., Yang G., Liu J., et al. Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J Biol Chem 2005, 280:39485-39492.
33. Min J.Y., Lim S.O., Jung G. Downregulation of catalase by reactive oxygen species via hypermethylation of CpG island II on the catalase promoter. FEBS Lett 2010, 584:2427-2432.
34. Oberley T.D., Oberley L.W. Antioxidant enzyme levels in cancer. Histol Histopathol 1997, 12:525-535.
35. Teoh-Fitzgerald M.L., Fitzgerald M.P., Jensen T.J., Futscher B.W., Domann F.E. Genetic and epigenetic inactivation of extracellular superoxide dismutase promotes an invasive phenotype in human lung cancer by disrupting ECM homeostasis. Mol Cancer Res 2012, 10:40-51.
36. Brandon M., Baldi P., Wallace D.C. Mitochondrial mutations in cancer. Oncogene 2006, 25:4647-4662.
37. Petros J.A., Baumann A.K., Ruiz-Pesini E., Amin M.B., Sun C.Q., Hall J., et al. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005, 102:719-724.
38. Ohsawa S., Sato Y., Enomoto M., Nakamura M., Betsumiya A., Igaki T. Mitochondrial defect drives non-autonomous tumour progression through Hippo signalling in Drosophila. Nature 2012, 490:547-551.
39. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
40. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239-252.
41. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
42. De Wever O., Nguyen Q.D., Van Hoorde L., Bracke M., Bruyneel E., Gespach C., et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 2004, 18:1016-1018.
43. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6:392-401.
44. Erez N., Truitt M., Olson P., Arron S.T., Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 2010, 17:135-147.
45. Pietras K., Sjoblom T., Rubin K., Heldin C.H., Ostman A. PDGF receptors as cancer drug targets. Cancer Cell 2003, 3:439-443.
46. Goetz J.G., Minguet S., Navarro-Lerida I., Lazcano J.J., Samaniego R., Calvo E., et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell 2011, 146:148-163.
47. Strutz F., Okada H., Lo C.W., Danoff T., Carone R.L., Tomaszewski J.E., et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995, 130:393-405.
48. Kraman M., Bambrough P.J., Arnold J.N., Roberts E.W., Magiera L., Jones J.O., et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science 2010, 330:827-830.
49. Goretzki L., Burg M.A., Grako K.A., Stallcup W.B. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J Biol Chem 1999, 274:16831-16837.
50. Sugimoto H., Mundel T.M., Kieran M.W., Kalluri R. Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 2006, 5:1640-1646.
51. Pula B., Jethon A., Piotrowska A., Gomulkiewicz A., Owczarek T., Calik J., et al. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. Histopathology 2011, 59:1249-1260.
52. Schoppmann S.F., Berghoff A., Dinhof C., Jakesz R., Gnant M., Dubsky P., et al. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Res Treat 2012, 134:237-244.
53. Neilson E.G. Mechanisms of disease: fibroblasts-a new look at an old problem. Nat Clin Pract Nephrol 2006, 2:101-108.
54. Radisky E.S., Radisky D.C. Stromal induction of breast cancer: inflammation and invasion. Rev Endocr Metab Disord 2007, 8:279-287.
55. Zavadil J., Haley J., Kalluri R., Muthuswamy S.K., Thompson E. Epithelial-mesenchymal transition. Cancer Res 2008, 68:9574-9577.
56. Zeisberg E.M., Potenta S., Xie L., Zeisberg M., Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res 2007, 67:10123-10128.
57. Qiu W., Hu M., Sridhar A., Opeskin K., Fox S., Shipitsin M., et al. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008, 40:650-655.
58. Direkze N.C., Hodivala-Dilke K., Jeffery R., Hunt T., Poulsom R., Oukrif D., et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004, 64:8492-8495.
59. Ishii G., Sangai T., Oda T., Aoyagi Y., Hasebe T., Kanomata N., et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 2003, 309:232-240.
60. Jeon E.S., Moon H.J., Lee M.J., Song H.Y., Kim Y.M., Cho M., et al. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 2008, 26:789-797.
61. Paunescu V., Bojin F.M., Tatu C.A., Gavriliuc O.I., Rosca A., Gruia A.T., et al. Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences. J Cell Mol Med 2011, 15:635-646.
62. Quante M., Tu S.P., Tomita H., Gonda T., Wang S.S., Takashi S., et al. Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011, 19:257-272.
63. Spaeth E.L., Dembinski J.L., Sasser A.K., Watson K., Klopp A., Hall B., et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009, 4:e4992.
64. Dirat B., Bochet L., Dabek M., Daviaud D., Dauvillier S., Majed B., et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 2011, 71:2455-2465.
65. Kidd S., Spaeth E., Watson K., Burks J., Lu H., Klopp A., et al. Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 2012, 7:e30563.
66. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 2007, 170:1807-1816.
67. Kojima Y., Acar A., Eaton E.N., Mellody K.T., Scheel C., Ben-Porath I., et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci USA 2010, 107:20009-20014.
68. Ronnov-Jessen L., Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993, 68:696-707.
69. Mueller L., Goumas F.A., Affeldt M., Sandtner S., Gehling U.M., Brilloff S., et al. Stromal fibroblasts in colorectal liver metastases originate from resident fibroblasts and generate an inflammatory microenvironment. Am J Pathol 2007, 171:1608-1618.
70. Ostman A., Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr Opin Genet Dev 2009, 19:67-73.
71. Jain M., Rivera S., Monclus E.A., Synenki L., Zirk A., Eisenbart J., et al. Mitochondrial reactive oxygen species regulate transforming growth factor-beta signaling. J Biol Chem 2013, 288:770-777.
72. Artaud-Macari E., Goven D., Brayer S., Hamimi A., Besnard V., Marchal-Somme J., et al. Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis. Antioxid Redox Signal 2013, 18:66-79.
73. Lee J.M., Calkins M.J., Chan K., Kan Y.W., Johnson J.A. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem 2003, 278:12029-12038.
74. Niethammer P., Grabher C., Look A.T., Mitchison T.J. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009, 459:996-999.
75. Radisky D.C., Levy D.D., Littlepage L.E., Liu H., Nelson C.M., Fata J.E., et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127.
76. Bae Y.S., Sung J.Y., Kim O.S., Kim Y.J., Hur K.C., Kazlauskas A., et al. Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 2000, 275:10527-10531.
77. Meng T.C., Fukada T., Tonks N.K. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 2002, 9:387-399.
78. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
79. Xu D., Rovira I.I., Finkel T. Oxidants painting the cysteine chapel: redox regulation of PTPs. Dev Cell 2002, 2:251-252.
80. Thannickal V.J., Day R.M., Klinz S.G., Bastien M.C., Larios J.M., Fanburg B.L. Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta1. FASEB J 2000, 14:1741-1748.
81. Salmeen A., Park B.O., Meyer T. The NADPH oxidases NOX4 and DUOX2 regulate cell cycle entry via a p53-dependent pathway. Oncogene 2010, 29:4473-4484.
82. Sotgia F., Martinez-Outschoorn U.E., Howell A., Pestell R.G., Pavlides S., Lisanti M.P. Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms. Annu Rev Pathol 2012, 7:423-467.
83. Martinez-Outschoorn U.E., Pavlides S., Whitaker-Menezes D., Daumer K.M., Milliman J.N., Chiavarina B., et al. Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors. Cell Cycle 2010, 9:2423-2433.
84. Martinez-Outschoorn U.E., Whitaker-Menezes D., Lin Z., Flomenberg N., Howell A., Pestell R.G., et al. Cytokine production and inflammation drive autophagy in the tumor microenvironment: role of stromal caveolin-1 as a key regulator. Cell Cycle 2011, 10:1784-1793.
85. Luanpitpong S., Talbott S.J., Rojanasakul Y., Nimmannit U., Pongrakhananon V., Wang L., et al. Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1. J Biol Chem 2010, 285:38832-38840.
86. Rosc-Schluter B.I., Hauselmann S.P., Lorenz V., Mochizuki M., Facciotti F., Pfister O., et al. NOX2-derived reactive oxygen species are crucial for CD29-induced pro-survival signalling in cardiomyocytes. Cardiovasc Res 2012, 93:454-462.
87. Hu M., Peluffo G., Chen H., Gelman R., Schnitt S., Polyak K. Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast. Proc Natl Acad Sci USA 2009, 106:3372-3377.
88. Hwang R.F., Moore T., Arumugam T., Ramachandran V., Amos K.D., Rivera A., et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008, 68:918-926.
89. Olumi A.F., Grossfeld G.D., Hayward S.W., Carroll P.R., Tlsty T.D., Cunha G.R. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999, 59:5002-5011.
90. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
91. Vicent S., Sayles L.C., Vaka D., Khatri P., Gevaert O., Chen R., et al. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res 2012, 72:5744-5756.
92. Yang G., Rosen D.G., Zhang Z., Bast R.C., Mills G.B., Colacino J.A., et al. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci USA 2006, 103:16472-16477.
93. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21:309-322.
94. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
95. Polyak K., Haviv I., Campbell I.G. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009, 25:30-38.
96. Bhowmick N.A., Chytil A., Plieth D., Gorska A.E., Dumont N., Shappell S., et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004, 303:848-851.
97. Guo X., Oshima H., Kitmura T., Taketo M.M., Oshima M. Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer. J Biol Chem 2008, 283:19864-19871.
98. Gaggioli C., Hooper S., Hidalgo-Carcedo C., Grosse R., Marshall J.F., Harrington K., et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007, 9:1392-1400.
99. Sanz-Moreno V., Gaggioli C., Yeo M., Albrengues J., Wallberg F., Viros A., et al. ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma. Cancer Cell 2011, 20:229-245.
100. Giannoni E., Bianchini F., Calorini L., Chiarugi P. Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness. Antioxid Redox Signal 2011, 14:2361-2371.
101. Giannoni E., Bianchini F., Masieri L., Serni S., Torre E., Calorini L., et al. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 2010, 70:6945-6956.
102. Giannoni E., Parri M., Chiarugi P. EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy. Antioxid Redox Signal 2012, 16:1248-1263.
103. Warburg O., Wind F., Negelein E. The metabolism of tumors in the body. J Gen Physiol 1927, 8:519-530.
104. Pavlides S., Whitaker-Menezes D., Castello-Cros R., Flomenberg N., Witkiewicz A.K., Frank P.G., et al. The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma. Cell Cycle 2009, 8:3984-4001.
105. Fiaschi T., Marini A., Giannoni E., Taddei M.L., Gandellini P., De Donatis A., et al. Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res 2012, 72:5130-5140.
106. Martinez-Outschoorn U.E., Balliet R.M., Rivadeneira D.B., Chiavarina B., Pavlides S., Wang C., et al. Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution: a new paradigm for understanding tumor metabolism, the field effect and genomic instability in cancer cells. Cell Cycle 2010, 9:3256-3276.
107. Whitaker-Menezes D., Martinez-Outschoorn U.E., Lin Z., Ertel A., Flomenberg N., Witkiewicz A.K., et al. Evidence for a stromal-epithelial lactate shuttle in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011, 10:1772-1783.
108. Witkiewicz A.K., Whitaker-Menezes D., Dasgupta A., Philp N.J., Lin Z., Gandara R., et al. Using the reverse Warburg effect to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle 2012, 11:1108-1117.
109. Park J.H., Kim T.Y., Jong H.S., Kim T.Y., Chun Y.S., Park J.W., et al. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells. Clin Cancer Res 2003, 9:433-440.
110. Ryu J.H., Li S.H., Park H.S., Park J.W., Lee B., Chun Y.S. Hypoxia-inducible factor alpha subunit stabilization by NEDD8 conjugation is reactive oxygen species-dependent. J Biol Chem 2011, 286:6963-6970.
111. Selak M.A., Armour S.M., MacKenzie E.D., Boulahbel H., Watson D.G., Mansfield K.D., et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005, 7:77-85.
112. Fiaschi T., Chiarugi P. Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison. Int J Cell Biol 2012, 2012:762825.
113. Ullah M.S., Davies A.J., Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006, 281:9030-9037.
114. Luo W., Hu H., Chang R., Zhong J., Knabel M., O'Meally R., et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011, 145:732-744.
115. Pelicano H., Lu W., Zhou Y., Zhang W., Chen Z., Hu Y., et al. Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Res 2009, 69:2375-2383.
116. Muller G., Lipp M. Signal transduction by the chemokine receptor CXCR5: structural requirements for G protein activation analyzed by chimeric CXCR1/CXCR5 molecules. Biol Chem 2001, 382:1387-1397.
117. Arora S., Bhardwaj A., Singh S., Srivastava S.K., McClellan S., Nirodi C.S., et al. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through ROS-dependent, NF-kappaB- and HIF-1alpha-mediated upregulation of CXCR4. J Biol Chem 2013.
118. Chen H.H., Su W.C., Lin P.W., Guo H.R., Lee W.Y. Hypoxia-inducible factor-1alpha correlates with MET and metastasis in node-negative breast cancer. Breast Cancer Res Treat 2007, 103:167-175.
119. Chetram M.A., Hinton C.V. ROS-mediated regulation of CXCR4 in cancer. Front Biol 2013, 8:273-278.
120. Comito G., Calvani M., Giannoni E., Bianchini F., Calorini L., Torre E., et al. HIF-1alpha stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radical Biol Med 2011, 51:893-904.
121. Scarpino S., Cancellario d'Alena F., Di Napoli A., Pasquini A., Marzullo A., Ruco L.P. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid. J Pathol 2004, 202:352-358.
122. Li Y.M., Pan Y., Wei Y., Cheng X., Zhou B.P., Tan M., et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 2004, 6:459-469.
123. Boimel P.J., Smirnova T., Zhou Z.N., Wyckoff J., Park H., Coniglio S.J., et al. Contribution of CXCL12 secretion to invasion of breast cancer cells. Breast Cancer Res 2012, 14:R23.
124. Hinton C.V., Avraham S., Avraham H.K. Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain. Clin Exp Metastasis 2010, 27:97-105.
125. Matsumoto K., Nakamura T. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions. Int J Cancer 2006, 119:477-483.
126. Jagadeeswaran R., Jagadeeswaran S., Bindokas V.P., Salgia R. Activation of HGF/c-Met pathway contributes to the reactive oxygen species generation and motility of small cell lung cancer cells. Am J Physiol Lung Cell Mol Physiol 2007, 292:L1488-L1494.
127. Margosio B., Marchetti D., Vergani V., Giavazzi R., Rusnati M., Presta M., et al. Thrombospondin 1 as a scavenger for matrix-associated fibroblast growth factor 2. Blood 2003, 102:4399-4406.
128. Chen J.K., Zhan Y.J., Yang C.S., Tzeng S.F. Oxidative stress-induced attenuation of thrombospondin-1 expression in primary rat astrocytes. J Cell Biochem 2011, 112:59-70.
129. Dvorak H.F., Galli S.J., Dvorak A.M. Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol 1986, 17:122-137.
130. Hurd T.R., DeGennaro M., Lehmann R. Redox regulation of cell migration and adhesion. Trends Cell Biol 2012, 22:107-115.
131. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 2002, 3:1129-1134.
132. Razzell W., Evans I.R., Martin P., Wood W. Calcium flashes orchestrate the wound inflammatory response through DUOX activation and hydrogen peroxide release. Curr Biol 2013, 23:424-429.
133. Feng Y., Santoriello C., Mione M., Hurlstone A., Martin P. Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation. PLoS Biol 2010, 8:e1000562.
134. Cordeiro J.V., Jacinto A. The role of transcription-independent damage signals in the initiation of epithelial wound healing. Nat Rev Mol Cell Biol 2013, 14:249-262.
135. Benink H.A., Bement W.M. Concentric zones of active RhoA and Cdc42 around single cell wounds. J Cell Biol 2005, 168:429-439.
136. 2+ signaling pathway promotes actin-mediated epidermal wound closure in C. elegans. Curr Biol 2011, 21:1960-1967.
137. Yoo S.K., Freisinger C.M., LeBert D.C., Huttenlocher A. Early redox, Src family kinase, and calcium signaling integrate wound responses and tissue regeneration in zebrafish. J Cell Biol 2012, 199:225-234.
138. Yin J., Xu K., Zhang J., Kumar A., Yu F.S. Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci 2007, 120:815-825.
139. Frijhoff J., Dagnell M., Godfreay R., Ostman A. Regulation of protein tyrosine phosphatase oxidation in cell adhesion and migration. Antioxid Redox Signal 2013 Oct10, In press.
140. Dagnell M., Frijhoff J., Pader I., Augsten M., Boivin B., Xu J., Mandal P.K., Tonks N.K., Hellberg C., Conrad M., Arnér E.S., Ostman A. Selective actvation of oxidized PTP1B by the thioredoxin system modulates PDGF-b receptor tyrosine kinase signaling. Proc Natl Acad Sci USA 2013, 110(33):13398-13403.
141. Calabrese C., Iommarini L., Kurelac I., Calvaruso M.A., Capristo M., Lollini P.L., et al. Respiratory complex I is essential to induce a Warburg profile in mitochondria-defective tumor cells. Cancer Metab 2013, (Mar (1)):1-11.
142. Caro P., Kishan A.U., Norberg E., Stanley I.A., Chapuy B., Ficarro S.B., et al. Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma. Cancer Cell 2012, 22(4):547-560.
143. Roesch A., Vultur A., Bogeski I., Wang H., Zimmermann K.M., Speicher D., et al. Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B (high) cells. Cancer Cell 2013, 23(6):811-825.